No Data
No Data
Hyphens Pharma Holds Insightful AGM
Hyphens Pharma International Reports First Quarter 2024 Earnings
Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1
Singapore's Straits Times Index slipped into the red zone on Wednesday, despite an overnight global rally following US inflation data that topped expectations. During the day, the benchmark Singapore
Hyphens Pharma's Q1 Net Profit Nearly Doubles on Broad-Based Sales Growth; Stock Climbs 6%
Hyphens Pharma International (SGX:1J5) nearly doubled its net profit in the first quarter, thanks to improved sales from all segments, especially in the specialty pharma principals unit, according to
Hyphens Pharma Reports Soaring Q1 Profits
Investors in Hyphens Pharma International (Catalist:1J5) Have Seen Favorable Returns of 75% Over the Past Five Years
No Data